FDMT 4D Molecular Therapeutics, Inc. - Common Stock
$8,75
السعر · مايو 20, 2026
البيانات الأساسية اعتبارًا من مايو 7, 2026
نطاق 52 أسبوعًا
$3–$12
60% of range
تقييم المحللين
BUY
17 analysts
السعر المستهدف
$28
+223% upside
P/E (TTM)
-3.1
ROE
-30.2%
هامش صافي الربح
-164.4%
FDMT لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$8.75
القيمة السوقية
$432M
P/E (TTM)
-3.1
ربح السهم (آخر 12 شهرًا)
$-2.42
الإيرادات (آخر 12 شهرًا)
$85M
عائد التوزيعات
—
ROE
-30.2%
D/E الدين/حقوق الملكية
—
نطاق 52 أسبوعًا
$3 – $12
FDMT مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$85M
2019-12-31
→
2025-12-31
ربح السهم
$-2.42
2021-12-31
→
2025-12-31
التدفق النقدي الحر
$-110M
2020-12-31
→
2025-12-31
الهوامش
-164.4%
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
FDMT
متوسط الأقران
P/E (TTM)
-3.1
15.2
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
5.1
62.3
P/B (السعر / القيمة الدفترية)
0.9
2.8
Price / FCF (السعر / التدفق النقدي الحر)
-3.9
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
FDMT
متوسط الأقران
Operating Margin (هامش التشغيل)
-187.2%
—
Net Profit Margin (هامش صافي الربح)
-164.4%
-240.1%
ROA (العائد على الأصول)
-24.9%
-25.8%
ROE
-30.2%
-29.9%
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
FDMT
متوسط الأقران
Current Ratio (النسبة الحالية)
9.4
9.1
Quick Ratio (النسبة السريعة)
9.2
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
FDMT
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
230194.6%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
200.9%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
44.3%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
FDMT
متوسط الأقران
FDMT توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
17 محللين
- شراء قوي 5 29,4%
- شراء 9 52,9%
- احتفاظ 3 17,6%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
9 محللين · 2026-05-16
الوسيط
$29.00
← أقل من جميع الأهداف
$8.75
منخفض
$17.00
مرتفع
$36.00
السعر المستهدف الوسيط
$29.00
+231,4%
السعر المستهدف المتوسط
$28.22
+222,5%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.18%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 31 مارس، 2026 | $-1.01 | $-1.01 | 0.00% |
| 31 ديسمبر، 2025 | $0.43 | $-0.78 | 1.2% |
| 30 سبتمبر، 2025 | $-1.01 | $-1.00 | -0.01% |
| 30 يونيو، 2025 | $-0.98 | $-0.89 | -0.09% |
| 31 مارس، 2025 | $-0.86 | $-0.88 | 0.02% |
| 31 ديسمبر، 2024 | $-0.90 | $-0.83 | -0.07% |
مقارنة النظراء المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | — |
| ACHV | — | -4.0 | — | — | — | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| REPL | $752M | -3.2 | — | — | -55.1% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 13
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37.0K | $21M | $3M | $18M | $14M | $7M | |
| SG&A Expense | $49M | $47M | $36M | $33M | $28M | $17M | $14M | |
| Operating Expenses | $245M | $188M | $134M | $113M | $89M | $70M | $58M | |
| Operating Income | $-160M | $-188M | $-113M | $-110M | $-71M | $-57M | $-51M | |
| Interest Income | $19M | $27M | $12M | $3M | $137.0K | $152.0K | $2M | |
| Other Non-op | $-37.0K | $-77.0K | $-181.0K | $-35.0K | $-121.0K | $-181.0K | $-46.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-140M | $-161M | $-101M | $-107M | $-71M | $-57M | $-49M | |
| EPS (Basic) | $-2.42 | $-2.98 | $-2.58 | $-3.32 | $-2.57 | · | · | |
| EPS (Diluted) | $-2.42 | $-2.98 | $-2.58 | $-3.32 | $-2.57 | · | · | |
| Shares (Basic) | 57,930,180 | 53,943,741 | 39,130,067 | 32,351,221 | 27,730,420 | · | · | |
| Shares (Diluted) | 57,930,180 | 53,943,741 | 39,130,067 | 32,351,221 | 27,730,420 | · | · | |
| EBITDA | $-160M | $-188M | $-113M | $-110M | $-71M | $-57M | · |
الميزانية العمومية 22
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $149M | $249M | $52M | $153M | $277M | $50M | |
| Short-term Investments | $342M | $276M | $39M | $161M | $95M | $0 | · | |
| Receivables | · | · | · | $0 | $47.0K | $1M | $978.0K | |
| Prepaid Expense | $10M | $10M | $8M | $7M | $8M | $4M | $2M | |
| Current Assets | $413M | $435M | $297M | $221M | $256M | $283M | $53M | |
| PP&E (Net) | $15M | $20M | $20M | $22M | $14M | $5M | $5M | |
| PP&E (Gross) | $36M | $36M | $32M | $30M | $20M | $9M | $8M | |
| Accum. Depreciation | $21M | $17M | $12M | $8M | $5M | $4M | $3M | |
| Other Non-current Assets | $9M | $4M | $684.0K | $1M | $602.0K | $602.0K | $677.0K | |
| Total Assets | $567M | $560M | $340M | $262M | $353M | $288M | $58M | |
| Accounts Payable | $11M | $4M | $4M | $3M | $5M | $2M | $2M | |
| Accrued Liabilities | $27M | $19M | $12M | $9M | $8M | $8M | · | |
| Current Liabilities | $44M | $29M | $19M | $16M | $16M | $17M | $13M | |
| Capital Leases | $16M | $19M | $12M | $13M | $15M | $0 | · | |
| Other Non-current Liabilities | $138.0K | $193.0K | $248.0K | $21.0K | $120.0K | $2M | $2M | |
| Total Liabilities | $61M | $50M | $32M | $31M | $34M | $32M | $28M | |
| Common Stock | $6.0K | $5.0K | $4.0K | $3.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-716M | $-576M | $-415M | $-314M | $-207M | $-136M | $-79M | |
| AOCI | $727.0K | $229.0K | $16.0K | $-1M | $-423.0K | $0 | · | |
| Stockholders' Equity | $506M | $511M | $308M | $231M | $319M | $256M | $-73M | |
| Liabilities + Equity | $567M | $560M | $340M | $262M | $353M | $288M | $58M | |
| Shares Outstanding | 57,607,874 | 45,793,942 | 43,075,218 | 32,626,627 | 32,224,524 | 26,681,983 | 5,178,955 |
التدفق النقدي 10
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $5M | $4M | $2M | $2M | $1M | $1M | |
| Stock-based Comp | $22M | $26M | $20M | $17M | $14M | $5M | $4M | |
| Operating Cash Flow | $-109M | $-135M | $-76M | $-87M | $-69M | $-51M | $-37M | |
| CapEx | $536.0K | $4M | $3M | $12M | $9M | $1M | $3M | |
| Investing Cash Flow | $-93M | $-302M | $116M | $-17M | $-173M | $-1M | $-3M | |
| Stock Issued | · | · | · | $0 | $114M | $206M | · | |
| Net Stock Activity | · | · | · | $0 | $114M | · | · | |
| Financing Cash Flow | $113M | $337M | $157M | $3M | $118M | $279M | $-2M | |
| Net Change in Cash | $-89M | $-100M | $197M | $-101M | $-124M | $227M | $-42M | |
| Free Cash Flow | $-110M | $-138M | $-79M | $-98M | $-78M | $-52M | · |
الربحية 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -187.2% | -507678.4% | -544.7% | -3516.5% | -395.5% | -416.3% | · | |
| Net Margin | -164.4% | -434778.4% | -486.6% | -3435.4% | -395.4% | -416.5% | · | |
| EBITDA Margin | -187.2% | -507678.4% | -544.7% | -3516.5% | -395.5% | -416.3% | · | |
| ROA | -24.9% | -35.7% | -33.5% | -34.9% | -22.2% | -32.7% | · | |
| ROE | -30.2% | -30.2% | -31.6% | -44.5% | -26.3% | -75.0% | · |
السيولة والملاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.4 | 14.9 | 15.7 | 14.0 | 15.7 | 16.9 | · | |
| Quick Ratio | 9.2 | 14.6 | 15.2 | 13.6 | 15.2 | 16.6 | · |
الكفاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | · | · | 133.1 | 23.5 | 11.0 | · |
معدلات النمو 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 230194.6% | -99.8% | 562.3% | -82.7% | 32.5% | · | · | |
| Revenue CAGR 3Y | 200.9% | -87.3% | 15.0% | · | · | · | · | |
| Revenue CAGR 5Y | 44.3% | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37.0K | $21M | $3M | $18M | $14M | · | |
| Net Income TTM | $-140M | $-161M | $-101M | $-107M | $-71M | $-57M | · | |
| Market Cap | $432M | $255M | $873M | $725M | $707M | $1.11B | · | |
| P/E | -3.1 | -1.9 | -7.9 | -6.7 | -8.5 | · | · | |
| P/S | 5.1 | 6893.8 | 42.1 | 231.6 | 39.2 | 81.2 | · | |
| P/B | 0.9 | 0.5 | 2.8 | 3.1 | 2.2 | 4.3 | · | |
| P / Tangible Book | 0.9 | 0.5 | 2.8 | 3.1 | 2.2 | 4.3 | · | |
| P / Cash Flow | -4.0 | -1.9 | -11.5 | -8.4 | -10.2 | -21.7 | · | |
| P / FCF | -3.9 | -1.8 | -11.1 | -7.4 | -9.0 | -21.3 | · | |
| Earnings Yield | -32.3% | -53.5% | -12.7% | -14.9% | -11.7% | · | · |
قائمة الدخل 13
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $85M | $90.0K | $15.0K | $14.0K | $1.0K | $3.0K | $5.0K | $28.0K | $-18.0K | $20M | $239.0K | $298.0K | $1M | $500.0K | $162.0K | |
| SG&A Expense | $12M | $13M | $12M | $12M | $13M | $13M | $13M | $11M | $10M | $11M | $9M | $9M | $8M | $8M | $8M | $8M | |
| Operating Expenses | $77M | $70M | $61M | $59M | $54M | $56M | $51M | $42M | $38M | $37M | $34M | $32M | $30M | $30M | $27M | $29M | |
| Operating Income | $-74M | $15M | $-61M | $-59M | $-54M | $-56M | $-51M | $-42M | $-38M | $-37M | $-14M | $-32M | $-30M | $-29M | $-26M | $-28M | |
| Interest Income | $5M | $5M | $4M | $5M | $6M | $6M | $7M | $8M | $6M | $4M | $4M | $3M | $1M | $1M | $795.0K | $340.0K | |
| Other Non-op | $-4.0K | $-22.0K | $-21.0K | $-61.0K | $67.0K | $-21.0K | $-1.0K | $-45.0K | $-10.0K | $-12.0K | $-158.0K | $8.0K | $-19.0K | $2.0K | $9.0K | $0 | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | |
| Net Income | $-69M | $19M | $-57M | $-55M | $-48M | $-50M | $-44M | $-35M | $-32M | $-32M | $-10M | $-30M | $-29M | $-27M | $-26M | $-28M | |
| EPS (Basic) | $-1.01 | $0.43 | $-1.01 | $-0.98 | $-0.86 | $-0.90 | $-0.79 | $-0.63 | $-0.66 | $-0.69 | $-0.24 | $-0.77 | $-0.88 | $-0.84 | $-0.79 | $-0.87 | |
| EPS (Diluted) | $-1.01 | $0.43 | $-1.01 | $-0.98 | $-0.86 | $-0.90 | $-0.79 | $-0.63 | $-0.66 | $-0.69 | $-0.24 | $-0.77 | $-0.88 | $-0.84 | $-0.79 | $-0.87 | |
| Shares (Basic) | 68,064,586 | -109,867,288 | 56,126,330 | 55,927,091 | 55,744,047 | -106,165,473 | 55,554,476 | 55,282,754 | 49,271,984 | -74,185,311 | 42,256,629 | 38,335,219 | 32,723,530 | -64,591,340 | 32,385,791 | 32,324,392 | |
| Shares (Diluted) | 68,064,586 | -109,867,288 | 56,126,330 | 55,927,091 | 55,744,047 | -106,165,473 | 55,554,476 | 55,282,754 | 49,271,984 | -74,185,311 | 42,256,629 | 38,335,219 | 32,723,530 | -64,591,340 | 32,385,791 | 32,324,392 | |
| EBITDA | $-74M | · | $-61M | $-59M | $-54M | · | $-51M | $-42M | $-38M | · | $-14M | $-32M | $-30M | · | $-26M | $-28M |
الميزانية العمومية 22
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72M | $60M | $49M | $77M | $134M | $149M | $188M | $189M | $276M | $249M | $276M | $236M | $79M | $52M | $108M | $113M | |
| Short-term Investments | $318M | $342M | $257M | $216M | $188M | $276M | $314M | $353M | $250M | $39M | $44M | $74M | $122M | $161M | $119M | $128M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Prepaid Expense | $14M | $10M | $7M | $10M | $11M | $10M | $9M | $11M | $10M | $8M | $9M | $7M | $7M | $7M | $5M | $5M | |
| Current Assets | $405M | $413M | $312M | $303M | $333M | $435M | $511M | $553M | $536M | $297M | $328M | $318M | $207M | $221M | $232M | $247M | |
| PP&E (Net) | $14M | $15M | $16M | $18M | $19M | $20M | $20M | $19M | $19M | $20M | $21M | $21M | $22M | $22M | $22M | $21M | |
| PP&E (Gross) | $36M | $36M | $36M | $36M | $36M | $36M | $35M | $33M | $33M | $32M | $32M | $31M | $30M | $30M | $29M | $27M | |
| Accum. Depreciation | $23M | $21M | $20M | $19M | $18M | $17M | $15M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | |
| Other Non-current Assets | $10M | $9M | $9M | $9M | $7M | $4M | $3M | $2M | $771.0K | $684.0K | $682.0K | $1M | $1M | $1M | $1M | $963.0K | |
| Total Assets | $513M | $567M | $424M | $474M | $516M | $560M | $604M | $620M | $630M | $340M | $362M | $353M | $244M | $262M | $280M | $303M | |
| Accounts Payable | $15M | $11M | $7M | $9M | $4M | $4M | $3M | $3M | $4M | $4M | $5M | $3M | $2M | $3M | $1M | $3M | |
| Accrued Liabilities | $23M | $27M | $24M | $19M | $16M | $19M | $21M | $13M | $9M | $12M | $10M | $7M | $5M | $9M | $7M | $6M | |
| Current Liabilities | $43M | $44M | $37M | $35M | $27M | $29M | $29M | $19M | $16M | $19M | $18M | $14M | $11M | $16M | $14M | $14M | |
| Capital Leases | $15M | $16M | $17M | $17M | $18M | $19M | $20M | $10M | $11M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | |
| Other Non-current Liabilities | $121.0K | $138.0K | $144.0K | $161.0K | $177.0K | $193.0K | $196.0K | $214.0K | $231.0K | $248.0K | $20.0K | $24.0K | $29.0K | $21.0K | $23.0K | $12.0K | |
| Total Liabilities | $61M | $61M | $55M | $53M | $46M | $50M | $51M | $32M | $29M | $32M | $32M | $27M | $25M | $31M | $29M | $30M | |
| Common Stock | $5.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-785M | $-716M | $-736M | $-679M | $-624M | $-576M | $-527M | $-483M | $-448M | $-415M | $-383M | $-373M | $-343M | $-314M | $-287M | $-261M | |
| AOCI | $-180.0K | $727.0K | $671.0K | $337.0K | $332.0K | $229.0K | $1M | $-293.0K | $-109.0K | $16.0K | $534.0K | $345.0K | $-270.0K | $-1M | $-2M | $-2M | |
| Stockholders' Equity | $452M | $506M | $369M | $421M | $470M | $511M | $553M | $588M | $601M | $308M | $330M | $325M | $219M | $231M | $251M | $273M | |
| Liabilities + Equity | $513M | $567M | $424M | $474M | $516M | $560M | $604M | $620M | $630M | $340M | $362M | $353M | $244M | $262M | $280M | $303M | |
| Shares Outstanding | 52,271,648 | 57,607,874 | 46,771,185 | 46,700,242 | 46,324,642 | 45,793,942 | 51,996,639 | 51,914,275 | 51,157,388 | 43,075,218 | 42,752,452 | 42,016,622 | 33,236,768 | 32,626,627 | 32,392,378 | 32,376,878 |
التدفق النقدي 9
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $994.0K | $1M | $1M | $1M | $517.0K | $466.0K | |
| Stock-based Comp | $4M | $6M | $5M | $5M | $7M | $8M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $5M | $4M | |
| Restructuring | · | · | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-68M | $29M | $-46M | $-43M | $-48M | $-46M | $-29M | $-30M | $-29M | $-25M | $-1M | $-22M | $-28M | $-22M | $-21M | $-20M | |
| CapEx | · | $-70.0K | $-91.0K | $66.0K | $631.0K | $949.0K | $2M | $349.0K | $710.0K | $549.0K | $405.0K | $805.0K | $1M | $1M | $2M | $2M | |
| Investing Cash Flow | $69M | $-129M | $18M | $-14M | $32M | $7M | $27M | $-74M | $-263M | $-7M | $30M | $49M | $43M | $-36M | $15M | $57M | |
| Financing Cash Flow | $11M | $112M | $116.0K | $862.0K | $0 | $601.0K | $568.0K | $17M | $319M | $5M | $11M | $131M | $11M | $2M | $460.0K | $-50.0K | |
| Net Change in Cash | $12M | $12M | $-29M | $-56M | $-16M | $-38M | $-2M | $-87M | $26M | $-27M | $39M | $158M | $26M | $-56M | $-5M | $38M | |
| Free Cash Flow | · | · | · | · | $-48M | · | · | · | $-30M | · | · | · | $-29M | · | · | · |
الربحية 5
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2416.2% | · | -67983.3% | -396373.3% | -383007.1% | · | -1704400.0% | -849120.0% | -136200.0% | · | -69.2% | -13446.0% | -10102.7% | · | -5299.0% | -17546.9% | |
| Net Margin | -2256.7% | · | -63195.6% | -364386.7% | -342657.1% | · | -1461433.3% | -699060.0% | -115717.9% | · | -50.8% | -12391.6% | -9624.8% | · | -5138.2% | -17337.0% | |
| EBITDA Margin | -2416.2% | · | -67983.3% | -396373.3% | -383007.1% | · | -1704400.0% | -849120.0% | -136200.0% | · | -69.2% | -13446.0% | -10102.7% | · | -5299.0% | -17546.9% | |
| ROA | -13.4% | · | -11.1% | -10.0% | -8.4% | · | -9.1% | -7.2% | -7.4% | · | -3.2% | -9.0% | -10.1% | · | -9.9% | -10.1% | |
| ROE | -14.9% | · | -12.3% | -10.8% | -9.0% | · | -9.9% | -7.6% | -7.9% | · | -3.5% | -9.9% | -11.2% | · | -10.8% | -10.9% |
السيولة والملاءة 2
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | · | 8.4 | 8.7 | 12.4 | · | 17.3 | 28.5 | 32.7 | · | 18.1 | 23.1 | 18.4 | · | 17.1 | 17.2 | |
| Quick Ratio | 9.0 | · | 8.2 | 8.5 | 11.9 | · | 17.0 | 27.9 | 32.1 | · | 17.6 | 22.6 | 17.8 | · | 16.8 | 16.8 |
الكفاءة 2
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 1.3 | 0.3 |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | · | $122.0K | $37.0K | $50.0K | · | $20M | $20M | $21M | · | $21M | $1M | $2M | · | $3M | $17M | |
| Net Income TTM | $-228M | · | $-203M | $-181M | $-159M | · | $-121M | $-107M | $-101M | · | $-94M | $-112M | $-109M | · | $-102M | $-84M | |
| Market Cap | $487M | · | $406M | $173M | $150M | · | $562M | $1.09B | $1.63B | · | $544M | $759M | $571M | · | $260M | $226M | |
| P/E | -2.4 | · | -2.4 | -1.1 | -1.1 | · | -4.7 | -9.1 | -12.5 | · | -4.8 | -5.5 | -5.1 | · | -2.4 | -2.5 | |
| P/S | 153.7 | · | 3331.5 | 4682.6 | 2992.6 | · | 27.8 | 53.2 | 78.5 | · | 25.6 | 633.2 | 262.2 | · | 80.2 | 13.0 | |
| P/B | 1.1 | · | 1.1 | 0.4 | 0.3 | · | 1.0 | 1.9 | 2.7 | · | 1.6 | 2.3 | 2.6 | · | 1.0 | 0.8 | |
| P / Tangible Book | 1.1 | · | 1.1 | 0.4 | 0.3 | · | 1.0 | 1.9 | 2.7 | · | 1.6 | 2.3 | 2.6 | · | 1.0 | 0.8 | |
| P / Cash Flow | -7.1 | · | · | · | -3.1 | · | · | · | -56.0 | · | · | · | -20.5 | · | · | · | |
| P / FCF | · | · | · | · | -3.1 | · | · | · | -54.7 | · | · | · | -19.8 | · | · | · | |
| Earnings Yield | -41.5% | · | -41.9% | -87.9% | -91.0% | · | -21.5% | -11.0% | -8.0% | · | -21.1% | -18.3% | -19.6% | · | -41.0% | -40.0% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $85M | $37.0K | $21M | $3M | $18M |
| هامش الربح التشغيلي % | -187.2% | -507678.4% | -544.7% | -3516.5% | -395.5% |
| صافي الدخل | $-140M | $-161M | $-101M | $-107M | $-71M |
| EPS المخفف | $-2.42 | $-2.98 | $-2.58 | $-3.32 | $-2.57 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 9.4 | 14.9 | 15.7 | 14.0 | 15.7 |
| النسبة السريعة | 9.2 | 14.6 | 15.2 | 13.6 | 15.2 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $-110M | $-138M | $-79M | $-98M | $-78M |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.